PRRT And The Neuroendocrine Tumor Treatment Algorithm
Cancer Network spoke with Dr. Shishir Maithel about grading and diagnosing neuroendocrine tumors and how PRRT best fits into the treatment algorithm of these tumors.
Endoscopic Resection Brings Excitement to Esophageal Cancer Treatment
Cancer Network spoke with Dr. Daniela Molena about the advancements in the treatment of esophageal cancer, including the safety and importance of endoscopic resection for the disease.
The Next Steps Beyond Cytotoxic Chemo in Pancreatic Cancer
Cancer Network spoke with Dr. Bassel El-Rayes about novel strategies on the horizon for pancreatic cancer during the 2019 ASCO Gastrointestinal Cancers Symposium.
Adjuvant Durvalumab Beneficial in Esophageal/GEJ Cancer?
Cancer Network spoke with Dr. Hirva Mamdani about the role and efficacy of adjuvant durvalumab in patients with Esophageal/GEJ Cancer.
Perioperative Immunotherapy the Future of HCC Treatment?
Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Using Radiation Therapy to Reduce Recurrence in DCIS
Cancer Network spoke with Dr. Carmen Bergom about advancements in the treatment of DCIS and the importance of using local recurrence patterns to help guide future research.
Targeting PI3K Remains Complex in Cancer Therapy
Dr. Lewis Cantley discusses targeting the PI3K pathway in breast cancer and the importance of managing ambient insulin levels during therapy.
Managing Patients With Moderate Penetrance Genes
Dr. Susan Domchek discusses the increased understanding of moderate penetrance genes and the importance of managing patients with these genes on a case-by-case basis.
KATHERINE Results Back New Adjuvant Standard for HER2+ Breast Cancer
Dr. Charles Geyer discusses the phase III KATHERINE trial, which compared ado-trastuzumab emtansine vs trastuzumab in HER2-positive early breast cancer.
Updates on Genetic Testing in Breast Cancer
In this video, Dr. Allison Kurian discusses polygenic risk scores, genetic testing in diverse populations, and more as they relate to breast cancer.
Can Circulating Tumor DNA Inform Breast Cancer Treatment?
In this video, Dr. Minetta Liu outlines current research into profiling breast cancer cell-free DNA in the blood, potentially to identify clinically aggressive breast cancer subtypes.
Exploring Current Tests, Treatments in Breast Cancer Management
In this video, Dr. Nancy Davidson highlights current and next-generation diagnostics and therapies in breast cancer, as well as the need for “team science” in clinical trials.
Bacterial Therapy May Be Promising in Cancer Patients
Dr. Filip Janku speaks with Cancer Network about a phase I clinical trial investigating the use of bacterial clostridium novyi-NT in solid tumors.
Why Haven’t Older Adults Been Included in More Oncology Clinical Trials?
In this video, Dr. Arti Hurria discusses resources addressing the disconnect between cancer as a growing problem in the elderly and the fact that clinical trials mostly enroll younger patients.
Tools and Tweaks to Improve Sleep Quality in Patients With Cancer
In this video, Dr. Jun Mao describes practical changes that have boosted sleep quality in cancer patients, and highlights results of a study showing sleep benefits from both CBT and acupuncture.
Men With Advanced Prostate Cancer, Be Informed About Your Genetics!
In this video, Dr. Heather Cheng briefly outlines the GENTleMEN study on the impact of genetic testing for men with advanced prostate cancer.
Strategies for Communicating Treatment Risks and Uncertainty of Outcomes
In this video, Professor Dame Lesley Fallowfield explains why oncologists need to be aware of their own tolerance of uncertainty before discussing possible treatment risks and outcomes with patients.
Liquid Biopsy to Inform Targeted Tx of Colorectal Cancer
In this video, Dr. Heinz-Josef Lenz outlines the many advantages that development of liquid biopsy is affording cancer patients.
AR-V7 Key in Tx of mCRPC
In this video, Dr. Andrew Armstrong explains why AR-V7–positive men rarely benefit from abiraterone or enzalutamide, and advises on AR-V7 testing as a clinical tool.
Can mRCC Patients Be Spared Debulking Nephrectomy?
In this video, Dr. Daniel George discusses CARMENA, which asked if cytoreductive surgery is necessary in the age of active systemic therapy for mRCC.
